Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis

Aktas, 2004, Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis, J. Immunol., 173, 5794, 10.4049/jimmunol.173.9.5794 Becanovic, 2003, New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis, J. Immunol., 170, 1062, 10.4049/jimmunol.170.2.1062 Bjartmar, 1999, Axonal pathology in myelin disorders, J. Neurocytol., 28, 383, 10.1023/A:1007010205037 Brück, 2005, Clinical implications of neuropathological findings in multiple sclerosis, J. Neurol., 252, iii10, 10.1007/s00415-005-2011-5 Butzkueven, 2002, LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival, Nat. Med., 8, 613, 10.1038/nm0602-613 DeKosky, 1996, Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain, Ann. Neurol., 39, 123, 10.1002/ana.410390118 Diem, 2001, Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo, J. Neurosci., 21, 2058, 10.1523/JNEUROSCI.21-06-02058.2001 Diem, 2003, Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo, Mol. Cell. Neurosci., 22, 487, 10.1016/S1044-7431(02)00042-8 Diem, 2003, Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway, J. Neurosci., 23, 6993, 10.1523/JNEUROSCI.23-18-06993.2003 Diem, 2005, Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis, Brain, 128, 375, 10.1093/brain/awh365 Ferguson, 1997, Axonal damage in acute multiple sclerosis lesions, Brain, 120, 393, 10.1093/brain/120.3.393 Gold, 2006, Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research, Brain, 129, 1953, 10.1093/brain/awl075 Griffiths, 1998, Axonal swellings and degeneration in mice lacking the major proteolipid of myelin, Science, 280, 1610, 10.1126/science.280.5369.1610 Hammarberg, 2000, Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells, J. Neurosci., 20, 5283, 10.1523/JNEUROSCI.20-14-05283.2000 Hashimoto, 2005, Inflammation-induced GDNF improves locomotor function after spinal cord injury, Neuroreport, 16, 99, 10.1097/00001756-200502080-00004 Hashimoto, 2005, Involvement of glial cell line-derived neurotrophic factor in activation processes of rodent macrophages, J. Neurosci. Res., 79, 476, 10.1002/jnr.20368 Heese, 1998, Inflammatory signals induce neurotrophin expression in human microglial cells, J. Neurochem., 70, 699, 10.1046/j.1471-4159.1998.70020699.x Herx, 2000, Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor, J. Immunol., 165, 2232, 10.4049/jimmunol.165.4.2232 Hobom, 2004, Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis, Brain Pathol., 14, 148, 10.1111/j.1750-3639.2004.tb00047.x Keegan, 2005, Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange, Lancet, 366, 579, 10.1016/S0140-6736(05)67102-4 Kermer, 2000, Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo, J. Neurosci., 20, 722, 10.1523/JNEUROSCI.20-02-00722.2000 Kerschensteiner, 1999, Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?, J. Exp. Med., 189, 865, 10.1084/jem.189.5.865 Kerschensteiner, 2003, Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases, Ann. Neurol., 53, 292, 10.1002/ana.10446 Klöcker, 1997, In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells, Neuroreport, 8, 3439, 10.1097/00001756-199711100-00005 Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 Leary, 2003, Interferon beta-1a in primary progressive multiple sclerosis, J. Neurol. Sci., 206, 215, 10.1016/S0022-510X(02)00350-7 Lindholm, 1987, Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve, Nature, 330, 658, 10.1038/330658a0 Linington, 1988, Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein, Am. J. Pathol., 130, 443 Linington, 1993, T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system, Eur. J. Immunol., 23, 1364, 10.1002/eji.1830230627 Linker, 2002, CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation, Nat. Med., 8, 620, 10.1038/nm0602-620 Lublin, 1996, Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, 46, 907, 10.1212/WNL.46.4.907 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann. Neurol., 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Maier, 2004, Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats, Brain Pathol., 14, 378, 10.1111/j.1750-3639.2004.tb00081.x Maier, 2006, Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study, Am. J. Pathol., 169, 1353, 10.2353/ajpath.2006.060159 Mathey, 2007, Neurofascin as a novel target for autoantibody-mediated axonal injury, J. Exp. Med., 204, 2363, 10.1084/jem.20071053 Moalem, 1999, Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy, Nat. Med., 5, 49, 10.1038/4734 Panitch, 2004, Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study, Neurology, 63, 1788, 10.1212/01.WNL.0000146958.77317.3E Sakuma, 2004, Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats, Brain, 127, 2201, 10.1093/brain/awh260 Satake, 2000, Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury, Neuroreport, 11, 3877, 10.1097/00001756-200011270-00054 Sättler (née Hobom), 2004, Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis, Cell. Death. Differ., 11, S181, 10.1038/sj.cdd.4401504 Sättler, 2005, Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis, Exp. Neurol., 193, 163, 10.1016/j.expneurol.2004.12.010 Sättler, 2006, Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions, Exp. Neurol., 201, 172, 10.1016/j.expneurol.2006.04.015 Schluesener, 1987, A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease, J. Immunol., 139, 4016, 10.4049/jimmunol.139.12.4016 Schroeter, 2003, CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction, Am. J. Pathol., 163, 1517, 10.1016/S0002-9440(10)63508-0 Secondary Progressinv Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group, 2001, Randomized controlled trial of interferon-beta-1a in secondary progressive MS: clinical results, Neurology, 56, 1496, 10.1212/WNL.56.11.1496 Shaftel, 2007, Chronic interleukin-1 expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood-brain barrier permeability without overt neurodegeneration, J. Neurosci., 27, 9301, 10.1523/JNEUROSCI.1418-07.2007 Sherriff, 1994, Markers of axonal injury in post mortem human brain, Acta Neuropathol. (Berl.), 88, 433, 10.1007/BF00389495 Smith, 2000, Autoimmune encephalomyelitis ameliorated by AMPA antagonists, Nat. Med., 6, 62, 10.1038/71548 Stadelmann, 2002, BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?, Brain, 125, 75, 10.1093/brain/awf015 Stefferl, 1999, Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response, J. Immunol., 163, 40, 10.4049/jimmunol.163.1.40 Storch, 1998, Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology, Brain Pathol., 8, 681, 10.1111/j.1750-3639.1998.tb00194.x Storch, 2006, Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related, J. Neuropathol. Exp. Neurol., 65, 1137, 10.1097/01.jnen.0000248547.13176.9d Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 Tullman, 2005, Combination therapy in multiple sclerosis, Curr. Neurol. Neurosci. Rep., 5, 245, 10.1007/s11910-005-0053-9 Vanderlocht, 2006, Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis, J. Neurosci. Res., 83, 763, 10.1002/jnr.20781 Weissert, 1998, MHC haplotype-dependent regulation of MOG-induced EAE in rats, J. Clin. Invest., 102, 1265, 10.1172/JCI3022 Weissert, 2001, MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis, J. Immunol., 166, 7588, 10.4049/jimmunol.166.12.7588 Yan, 1999, Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF), J. Neurobiol., 38, 382, 10.1002/(SICI)1097-4695(19990215)38:3<382::AID-NEU7>3.0.CO;2-5 Yoles, 2001, Protective autoimmunity is a physiological response to CNS trauma, J. Neurosci., 21, 3740, 10.1523/JNEUROSCI.21-11-03740.2001